Loading clinical trials...
Loading clinical trials...
Positron Emission Tomography for the Detection of Subclinical Immune Checkpoint Inhibitor-Induced Myocarditis (PET-SIM): A Prospective, Single Center, Single Arm, Open Label Pilot Study
Conditions
Interventions
Fluorodeoxyglucose - Positron Emission Tomography (FDG-PET)
Locations
1
United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Start Date
October 11, 2024
Primary Completion Date
April 30, 2027
Completion Date
April 30, 2027
Last Updated
October 15, 2025
NCT05046002
NCT07359690
NCT07354646
NCT05295290
NCT05335928
NCT06060548
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions